PL3423111T3 - Związek, sposób jego otrzymywania, roztwór farmaceutyczny zawierający związek, sposób określania obecności choroby nowotworowej, zestaw do wykrywania nowotworów oraz zastosowanie hydrolizy związku do wykrywania nowotworów - Google Patents
Związek, sposób jego otrzymywania, roztwór farmaceutyczny zawierający związek, sposób określania obecności choroby nowotworowej, zestaw do wykrywania nowotworów oraz zastosowanie hydrolizy związku do wykrywania nowotworówInfo
- Publication number
- PL3423111T3 PL3423111T3 PL17727737.3T PL17727737T PL3423111T3 PL 3423111 T3 PL3423111 T3 PL 3423111T3 PL 17727737 T PL17727737 T PL 17727737T PL 3423111 T3 PL3423111 T3 PL 3423111T3
- Authority
- PL
- Poland
- Prior art keywords
- compound
- cancer
- detection
- hydrolysis
- kit
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/976—Trypsin; Chymotrypsin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL416395A PL231469B1 (pl) | 2016-03-04 | 2016-03-04 | Nowy związek, sposób jego otrzymywania, roztwór farmaceutyczny zawierający nowy związek, sposób określania obecności choroby nowotworowej, zestaw do wykrywania nowotworów oraz zastosowanie hydrolizy nowego związku do wykrywania nowotworów |
| PCT/PL2017/000018 WO2017150997A1 (en) | 2016-03-04 | 2017-03-03 | Compound, process for its preparation, a pharmaceutical solution containing the compound, a method of determining the presence of cancer, a kit for cancer detection, and the use of hydrolysis of the compound for the detection of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3423111T3 true PL3423111T3 (pl) | 2024-09-02 |
Family
ID=58995198
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL416395A PL231469B1 (pl) | 2016-03-04 | 2016-03-04 | Nowy związek, sposób jego otrzymywania, roztwór farmaceutyczny zawierający nowy związek, sposób określania obecności choroby nowotworowej, zestaw do wykrywania nowotworów oraz zastosowanie hydrolizy nowego związku do wykrywania nowotworów |
| PL17727737.3T PL3423111T3 (pl) | 2016-03-04 | 2017-03-03 | Związek, sposób jego otrzymywania, roztwór farmaceutyczny zawierający związek, sposób określania obecności choroby nowotworowej, zestaw do wykrywania nowotworów oraz zastosowanie hydrolizy związku do wykrywania nowotworów |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL416395A PL231469B1 (pl) | 2016-03-04 | 2016-03-04 | Nowy związek, sposób jego otrzymywania, roztwór farmaceutyczny zawierający nowy związek, sposób określania obecności choroby nowotworowej, zestaw do wykrywania nowotworów oraz zastosowanie hydrolizy nowego związku do wykrywania nowotworów |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US10556925B2 (pl) |
| EP (1) | EP3423111B1 (pl) |
| PL (2) | PL231469B1 (pl) |
| WO (1) | WO2017150997A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL238871B1 (pl) * | 2018-02-13 | 2021-10-18 | Univ Gdanski | Peptydomimetyk oraz jego zastosowanie jako środek fluorescencyjny in vitro |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL224854B1 (pl) * | 2013-08-23 | 2017-02-28 | Univ Warszawski | Nowy peptydomimetyk o aktywności antyangiogennej i zawierająca go kompozycja farmaceutyczna |
-
2016
- 2016-03-04 PL PL416395A patent/PL231469B1/pl unknown
-
2017
- 2017-03-03 PL PL17727737.3T patent/PL3423111T3/pl unknown
- 2017-03-03 WO PCT/PL2017/000018 patent/WO2017150997A1/en not_active Ceased
- 2017-03-03 EP EP17727737.3A patent/EP3423111B1/en active Active
- 2017-03-03 US US16/082,032 patent/US10556925B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017150997A1 (en) | 2017-09-08 |
| US10556925B2 (en) | 2020-02-11 |
| EP3423111A1 (en) | 2019-01-09 |
| PL231469B1 (pl) | 2019-02-28 |
| US20190248835A1 (en) | 2019-08-15 |
| EP3423111B1 (en) | 2023-08-16 |
| PL416395A1 (pl) | 2017-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3443119B8 (en) | Methods for lung cancer detection | |
| SMT202100566T1 (it) | Reagente di rivelazione/diagnosi molecolare per tumore | |
| EP3156498A4 (en) | Breast cancer detection kit or device, and method for detecting breast cancer | |
| EP3159416A4 (en) | Kit or device for detecting lung cancer, and lung cancer detection method | |
| EP3370603A4 (en) | SYSTEM AND METHOD FOR DETECTING BLOOD UNDER THE SURFACE | |
| EP3242947A4 (en) | Method for the treatment of malignancies | |
| EP3168624A4 (en) | Substance sealing method and target molecule detecting method | |
| IL254687A0 (en) | A bio-sensor system for rapid identification of an analyte | |
| EP3280408A4 (en) | Process for the preparation of dicycloplatin | |
| EP3183578B8 (en) | Methods for the early detection of colorectal cancer | |
| EP3115467A4 (en) | Method for assisting detection of pancreatic cancer | |
| GB2533072B (en) | Method for the processing of an aqueous hemicellulosic stream | |
| EP3250904A4 (en) | Multi-threaded fluid parameter signal processing | |
| AU2016248025B2 (en) | Polymorphs of AFATINIB and its salts and process for the preparation of quinazolinyl derivatives | |
| GB201602210D0 (en) | Detection of cancer | |
| PL3380983T3 (pl) | Sposób identyfikacji procesora bezpieczeństwa | |
| GB201906201D0 (en) | Method for the detection of protate cancer | |
| EP3252469A4 (en) | Method for simultaneous detection of blood cells having interacting molecules | |
| GB201517279D0 (en) | Method and system for improving the evaluation of an interaction between an analyte and a ligand using a biosensor | |
| EP3637106A4 (en) | LUNG CANCER DETECTION PROCEDURE | |
| PL3423111T3 (pl) | Związek, sposób jego otrzymywania, roztwór farmaceutyczny zawierający związek, sposób określania obecności choroby nowotworowej, zestaw do wykrywania nowotworów oraz zastosowanie hydrolizy związku do wykrywania nowotworów | |
| EP3540630A4 (en) | METHOD OF DETECTING GLITTER | |
| GB2564185B (en) | Process for the preparation of derivatives of benzodioxole | |
| EP3108256A4 (en) | Method of detecting cancer | |
| EP3140308B8 (en) | Process for the preparation of opioid compounds |